The Cardiac Ledger

Market Access Letter

Letters in this series from The Cardiac Ledger, newest first.

Market Access Letter letters

  • Breakthrough Lost Its Medicare Edge

    Since October 1, 2026, Breakthrough designation no longer exempts most devices from the substantial clinical improvement test for NTAP and pass-through. RAPID coverage is still a proposal. A 2027 plan has to carry those two facts on separate timelines.

  • The TAVR Rule Left One Group of Patients Out

    CMS's September 10, 2026 TAVR decision covers symptomatic severe aortic stenosis without a study requirement, while asymptomatic patients are covered only in a CMS-approved study. The two timelines differ, and plans should treat them separately.